Liliana  Fernández Canigia

Liliana Fernández Canigia

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2023 in Microbial Genomics
Verified
Journal Article
Open access
SGSabrina Di Gregorio
Sabrina Di Gregorio
JVJesús Vielma
Jesús Vielma
MHMaría Sol Haim
María Sol Haim
LRLucía Rago
Lucía Rago
JCJosefina Campos
Josefina Campos
MMMarta Mollerach
Marta Mollerach
Staphylococcus aureus remains one of the leading causes of infections worldwide and a common cause of bacteraemia. However, studies documenting the epidemiology of S. aureus in South America using genomics are scarce. We hereby report on the largest genomic epidemiology study to date of both methicillin-resistant S. aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) in South America, conducted by the StaphNET-SA network. We characterised 404 genomes recovered from a prospective observational study of S. aureus bacteraemia in 58 hospitals from Argentina, Bolivia, Brazil, Paraguay and Uruguay between April and October 2019. We show that a minority of S. aureus isolates are phenotypically multi-drug resistant (5.2%), but more than a quarter are resistant to macrolide–lincosamide–streptogramin B (MLSb). MSSA were more genetically diverse than MRSA. Lower rates of associated antimicrobial resistance in community-associated(CA)-MRSA versus hospital-associated (HA)-MRSA were found in association with three S. aureus genotypes dominating the MRSA population: CC30-MRSA-IVc-t019-lukS/F-PV+, CC5-MRSA-IV-t002-lukS/F-PV- and CC8-MRSA-IVc-t008-lukS/F-PV+-COMER+. These are historically from a CA origin, carry on average fewer antimicrobial resistance determinants, and often lack key virulence genes. Surprisingly, CC398-MSSA-t1451-lukS/F-PV- related to the CC398 human-associated lineage is widely disseminated throughout the region, and is described here for the first time as the most prevalent MSSA lineage in South America. Moreover, CC398 strains carrying ermT (largely responsible for the MLSb resistance rates of MSSA strains: inducible iMLSb phenotype) and sh_fabI (related to triclosan resistance) were recovered from both CA and HA origin. The frequency of MRSA and MSSA lineages differed between countries but the most prevalent S. aureus genotypes are high-risk clones widely distributed in the South American region without a clear country-specific phylogeographical structure. Therefore, our findings underline the need for continuous genomic surveillance by regional networks such as StaphNET-SA. This article contains data hosted by Microreact.

22 June 2023 in Pathogens
Verified
Journal Article
Open access
PDF file
ACAgustina Costa
Agustina Costa
RFRoque Figueroa-Espinosa
Roque Figueroa-Espinosa
JMJerson A. Martínez
Jerson A. Martínez
LCLiliana Fernández Canigia
Liliana Fernández Canigia
MMMaría I. Maldonado
María I. Maldonado
José Alejandro Di ConzaJosé Alejandro Di Conza
José Alejandro Di Conza
Carbapenemase resistance in Enterobacterales is a global public health problem and rapid and effective methods for detecting these resistance mechanisms are needed urgently. Our aim was to evaluate the performance of a MALDI-TOF MS-based “Klebsiella pneumoniae carbapenemase” (KPC) detection protocol from patients’ positive blood cultures, short-term cultures, and colonies in healthcare settings. Bacterial identification and KPC detection were achieved after protein extraction with organic solvents and target spot loading with suitable organic matrices. The confirmation of KPC production was performed using susceptibility tests and blaKPC amplification using PCR and sequencing. The KPC direct detection (KPC peak at approximately 28.681 Da) from patients’ positive blood cultures, short-term cultures, and colonies, once bacterial identification was achieved, showed an overall sensibility and specificity of 100% (CI95: [95%, 100%] and CI95: [99%, 100%], respectively). The concordance between hospital routine bacterial identification protocol and identification using this new methodology from the same extract used for KPC detection was ≥92%. This study represents the pioneering effort to directly detect KPC using MALDI-TOF MS technology, conducted on patient-derived samples obtained from hospitals for validation purposes, in a multi-resistance global context that requires concrete actions to preserve the available therapeutic options and reduce the spread of antibiotic resistance markers.
2

1 January 2009 in Chemotherapy
Verified
Journal Article
Closed access
LCLiliana Fernández Canigia
Liliana Fernández Canigia
SKSara Kaufman
Sara Kaufman
LLLiliana Lanata
Liliana Lanata
CVCarlos Vay
Carlos Vay
MGMarta Giovanakis
Marta Giovanakis
CBCarlos Bantar
Carlos Bantar
Tigecycline is a new antibiotic currently used in healthcare environments where multidrug resistance is prominent. Because there is a constant potential for resistance to emerge, survey studies are needed. Isolates collected in 20 clinical laboratories from 4 states of Argentina between November 2005 and October 2006 were tested using the disk diffusion method as described by the CLSI. A total of 3,182 isolates were assessed. Gram-positive cocci represented 43.4% of the total isolates [Staphylococcus aureus (878), coagulase-negative staphylococci (255), Enterococcus spp. (201), Streptococcus spp. (47)], Enterobacteriaceae 39.6% and Acinetobacter spp. 11.1%. Tigecycline proved equally active against methicillin-resistant and methicillin-susceptible staphylococci, as well as against vancomycin-resistant and vancomycin-susceptible enterococci (100% of susceptibility for all Gram-positive bacteria tested). Tigecycline susceptibility for Enterobacteriaceae, other than Proteeae tribe and Serratia spp., ranged from 88 to 100%, including against strains with resistance to third-generation cephalosporins with phenotype of extended spectrum beta-lactamases (extended spectrum beta-lactamase-positive Escherichia coli 17.7% and extended spectrum beta-lactamase-positive Klebsiella pneumoniae 50.5%). Adopting a resistant breakpoint of 16 mm, 92% of the Acinetobacter isolates were susceptible to tigecycline. Tigecycline was active against a wide variety of bacterial species, including most of the multidrug-resistant Gram-negative and Gram-positive bacteria. Therefore, it could be a suitable option in the treatment of infections caused by these organisms in hospitalized patients.

1 June 1999 in Anaerobe
Verified
Journal Article
Closed access
LCLiliana Fernández Canigia
Liliana Fernández Canigia
AMAna Di Martino
Ana Di Martino
MLMirta Litterio
Mirta Litterio
LCLiliana Castello
Liliana Castello
MFMarı́a I. Fernández
Marı́a I. Fernández
HBHebe Bianchini
Hebe Bianchini

31 May 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
ACAgustina Costa
Agustina Costa
RFRoque Figueroa-Espinosa
Roque Figueroa-Espinosa
JMJerson Andrés Martínez
Jerson Andrés Martínez
LCLiliana Fernández Canigia
Liliana Fernández Canigia
MMMaría Ivana Maldonado
María Ivana Maldonado
José Alejandro Di ConzaJosé Alejandro Di Conza
José Alejandro Di Conza
Carbapenemase resistance in Enterobacterales is a global public health problem and rapid and effective methods to detect resistance mechanisms are needed urgently. Our aim was to evaluate the performance of a MALDI-TOF MS based KPC detection protocol from patients’ positive blood cultures, short-term cultures and colonies at health care settings. Bacterial identification and KPC detection were achieved after protein extraction with organic solvents and target spot loading with suitable organic matrices. Confirmation of KPC production was performed by susceptibility tests, blaKPC amplification by PCR and sequencing. KPC direct detection (KPC-peak at approximately 28.681 Da) from patients’ positive blood cultures, short-term cultures and colonies, once bacterial identification was achieved, showed an overall sensibility and specificity of 100% (CI95: [95%,100%] and CI95: [99%, 100%], respectively). Concordance between hospital routine bacterial identification protocol and identification with this new methodology from the same extract used for KPC detection was ≥92%. This study represents the pioneering effort to directly detect KPC using MALD-TOF MS technology, conducted on patient-derived samples obtained at the hospitals for validation purposes, in a multi-resistance global context that requires concrete actions to preserve available therapeutic options and reduce the spread of antibiotic resistance markers.

20 December 2022 in medRxiv
Verified
Preprint
Open access
PDF file
SGSabrina Di Gregorio
Sabrina Di Gregorio
JVJesús Vielma
Jesús Vielma
MHMaría Sol Haim
María Sol Haim
LRLucía Rago
Lucía Rago
JCJosefina Campos
Josefina Campos
SCStaphNET-SA consortium
StaphNET-SA consortium
Staphylococcus aureus remains one of the leading causes of infections worldwide and a common cause of bacteremia. However, studies documenting the epidemiology of S. aureus in South America (SA) using genomics are scarce. We hereby report on the largest to date genomic epidemiology study of both methicillin-resistant S. aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) in SA, conducted by the StaphNET-SA network. We characterised 404 genomes recovered from a prospective observational study of S. aureus bacteremia in 58 hospitals from Argentina, Bolivia, Brazil, Paraguay and Uruguay between April and October 2019. We show that a minority of S. aureus isolates are phenotypically multi-drug resistant (5.2%), but more than a quarter are resistant to macrolide-lincosamide-streptogramin B (MLSb). MSSA were more genetically diverse than MRSA. Lower rates of associated antimicrobial resistance in CA-MRSA vs HA-MRSA were found in association with three S. aureus genotypes dominating the MRSA population: CC30-MRSA-IVc- t019 - lukS/F-PV+ , CC5-MRSA-IV- t002 - lukS/F-PV- , and CC8-MRSA-IVc- t008 - lukS/F-PV+ -COMER+. These are historically from a CA origin, carry on average less AMR determinants, and often lack key virulence genes. Surprisingly, CC398-MSSA- t1451 - lukS/F-PV- related to the CC398 human-associated lineage is widely disseminated throughout the region, and is described here for the first time as the most prevalent MSSA lineage in SA. Moreover, CC398 strains carrying ermT and sh_fabI (related to triclosan resistance) were recovered from both CA and HA origin, and are largely responsible for the MLSb rates of MSSA strains (inducible iMLSb phenotype). The frequency of MRSA and MSSA lineages differed between countries but the most prevalent S. aureus genotypes are high-risk clones widespread in the South American region without clear country-specific phylogeographic structure. Therefore our findings underscore the need for continuous genomic surveillance by regional networks such as StaphNET-SA. Impact statement: S. aureus is a common cause of bacteremia, a serious life threatening disease, and the second leading pathogen for deaths associated with resistance in 2019. However, genomic surveillance of S. aureus causing invasive infections in South America is limited. Previous surveillance studies have focused on the dissemination of MRSA with increasing AMR and/or virulence, but have not characterised MSSA in detail. Here, we show the results of a prospective observational study of genomic surveillance of S. aureus causing bacteremia conducted in South America during 2019 by the StaphNET-SA network. Our study reveals that in 2019 most bloodstream infections were caused by successful MRSA lineages of community origin, generally not MDR, and lacking key virulence genes in some cases. Importantly, we also describe here for the first time CC398-MSSA- t1451 as the most prevalent and widely disseminated MSSA clone causing bacteraemia in the region during 2019. This human adapted clone, present both in the community and hospital environment, carries a gene conferring resistance against an antiseptic widely used in our region, and is largely responsible for the increasing resistance rates to erythromycin and clindamycin observed in MSSA. We also show evidence of readily transmission of the most prevalent MRSA and MSSA high-risk clones across country borders, which highlights the need for continuous genomic surveillance by regional networks such as StaphNET-SA. Data Summary: All supporting data, code and protocols have been provided within the article or through supplementary data files. Five supplementary figures and five supplementary tables are available with the online version of this article. Sequence read files for all samples used in this study have been deposited in the European Nucleotide Archive under the project accession number PRJEB37318. Individual accession numbers for each sample are also detailed in microreact_project: https://microreact.org/project/staphnet-sa-1st-survey . Genome assemblies are available via Pathogenwatch https://pathogen.watch/collection/jz7rcy1zv0sk-staphnet-sa-first-survey .